Artificial Tears Market

Date: 2016-05

Eye drops that are typically used to treat irritation and dryness of eyes are called artificial tears. Comprised of polymers and water and salts, artifial tears, as the name suggests, are made to resemble real eye tears and address a number of eye problems. However, as opposed to real eye tears, artificial tears do not contain any proteins. One of the main diseases being addressed by artificial tears is dry eye syndrome (DES). This is also one of the key factors driving the growth of this market. DES is condition being reported not only amongst senior citizens, but even across the young generation of individuals. The reason for this is the kind of lifestyle being led by the young working class that involves poor dietary intake and long hours in front of a computer, phone or tablet. Apart from this, frequent air travel and rising pollution levels are other factors attributing to the rise of DES. Also, the probablity of being affected with DES increases with age and contact lens users are also more susceptible to this condition. Artificial tears are usually the first line of medication prescribed by any physician for symptoms related to DES.

While artificial tears are easily available over the counter remedies for DES, the use of artificial tears also has side effects that need to be kept in mind. Also, with some patients who require the use of artificial tears several times a day, regular artificial tears are not a good option. Technological advances associated with several years of research and development has addressed this issue with preservative free artificial tears.Artificial Tears Market

The Artificial Tears market can be segmented on the basis of type as
Cellulose-derived tears
Glycerin-derived tears
polyethylene glycol and propylene glycol based tears
Oil-based emulsion tears

In terms of end-user age group, the Artificial Tears market has been segmented across the following:
20-40 years
40-60 years
Above 60 years of age

While the growth potential in regions such as Europe and North America still exist, the opportunities in developing economies in South America and APAC are poised to grow at higher rates comparatively. In Europe, an increasing ageing population is one aspect that will enhance the growth of the market. Changing lifestyles resulting in an increasing number of DES patients coupled with the increasing spending power of the population in these regions is expected to drive the growth of the artificial tear market in South America and Asia Pacific.

The market has been segmented based on the following geographies:
North America
South America
Middle East

Following are just a few of the companies that are operating in the Artificial Tears market:
Abott Medical Optics Inc
Akorn Inc
Johnson & Johnson
Bausch and Lomb


Contact With Us
Join templatemonster at google+
Customized Research
Request Sample